| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SANA | Sana Biotechnology, Inc. | EVP, Head of Development & CMO | $6.2M | Mar 3, 2022 | ||
| ARVN | ARVINAS, INC. | Director | $435K | Jun 25, 2025 | ||
| ATXS | Astria Therapeutics, Inc. | Director | Jun 11, 2025 | |||
| CALA | Calithera Biosciences, Inc. | Director | Jun 1, 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|